Asarfi Hospital Ltd

From a 52-week low of Rs 82 to a fresh high of Rs 222.35 on 15 Jun 2026, Asarfi Hospital Ltd has surged over 161% in the past year, significantly outpacing the Sensex’s modest 1.76% gain. This remarkable price momentum is underpinned by a confluence of bullish technical indicators and sustained upward price action.

After a brief pause following two consecutive days of gains, Asarfi Hospital Ltd surged to a fresh all-time high of Rs 218 on 15 Apr 2026, extending its remarkable rally over the past year. This milestone caps a period of exceptional outperformance against the broader market, with the stock delivering a 156.47% return in the last 12 months compared to the Sensex’s modest 1.52% gain.

Asarfi Hospital Ltd has seen its investment rating upgraded from Buy to Strong Buy, reflecting significant improvements across technical indicators, valuation metrics, financial trends, and overall quality. This upgrade, effective from 13 April 2026, comes amid robust stock performance and solid quarterly results, positioning the micro-cap hospital sector player favourably against market benchmarks.

Asarfi Hospital Ltd has recently undergone a notable shift in its valuation parameters, moving from a very attractive to an attractive rating. This change, coupled with robust financial metrics and strong market performance, positions the micro-cap hospital stock as a compelling prospect for investors seeking value in the healthcare sector.

Asarfi Hospital Ltd has witnessed a notable upgrade in its valuation parameters, shifting from a very attractive to an attractive rating, reflecting improved price appeal amid robust operational metrics and a strong market performance. This micro-cap hospital stock’s recent re-rating comes alongside a significant price appreciation and favourable comparisons with peers and the broader Sensex index.

Asarfi Hospital Ltd is rated Buy by MarketsMOJO, with this rating last updated on 25 March 2026. However, the analysis and financial metrics presented here reflect the company’s current position as of 06 April 2026, providing investors with the most up-to-date insight into the stock’s fundamentals, returns, and overall outlook.

Asarfi Hospital Ltd has been upgraded from a Hold to a Buy rating, reflecting significant improvements across multiple key parameters including quality, valuation, financial trends, and technical indicators. This upgrade, announced on 25 March 2026, follows a period of robust financial performance and positive market momentum, positioning the micro-cap hospital stock as a compelling investment opportunity amid a challenging healthcare sector landscape.

Asarfi Hospital Ltd has seen its investment rating downgraded from Buy to Hold as of 23 March 2026, reflecting a nuanced reassessment across quality, valuation, financial trends, and technical indicators. Despite robust financial performance and attractive valuation metrics, evolving technical signals and a cautious outlook on long-term growth have prompted a more measured stance from analysts.

Asarfi Hospital Ltd has seen its investment rating upgraded from Hold to Buy, reflecting a marked improvement across key parameters including quality, valuation, financial trends, and technical indicators. This upgrade, effective from 18 Mar 2026, is underpinned by robust quarterly results, attractive valuation metrics, and a shift towards a mildly bullish technical trend, signalling renewed investor confidence in this micro-cap hospital stock.

Asarfi Hospital Ltd’s investment rating has been downgraded from Buy to Hold as of 13 March 2026, primarily driven by a shift in technical indicators despite the company’s robust financial performance and attractive valuation metrics. This recalibration reflects a more cautious stance amid sideways technical trends and mixed market signals, even as the hospital continues to demonstrate strong profitability and debt servicing capabilities.

Asarfi Hospital Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 March 2026. While the rating was revised on that date, the analysis and financial metrics presented here reflect the company’s current position as of 15 March 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and technical outlook.

Asarfi Hospital Ltd has been upgraded from a Hold to a Buy rating following a comprehensive reassessment of its quality, valuation, financial trend, and technical indicators. The company’s robust quarterly performance, attractive valuation metrics, and a shift towards a mildly bullish technical trend have collectively driven this positive change in investment stance.

Asarfi Hospital Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 16 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 February 2026, providing investors with the latest insights into the company’s performance and outlook.

Asarfi Hospital Ltd has witnessed a significant improvement in its valuation parameters, with its price-to-earnings (P/E) and price-to-book value (P/BV) ratios shifting from attractive to very attractive levels. This re-rating comes amid robust stock returns and favourable operational metrics, positioning the hospital sector player as a compelling investment opportunity in the current market environment.

Asarfi Hospital Ltd has delivered an exceptional quarterly performance for the December 2025 quarter, prompting an upgrade in its financial trend rating from ‘Very Positive’ to ‘Outstanding’. The hospital’s robust revenue growth, margin expansion, and return metrics have set new benchmarks, signalling strong operational execution and financial discipline amid a competitive healthcare sector.

Asarfi Hospital Ltd has been upgraded from a Hold to a Buy rating following a comprehensive reassessment of its quality, valuation, financial trends, and technical indicators. The upgrade reflects the company’s robust quarterly financial performance, attractive valuation metrics, and a shift towards a more bullish technical outlook, signalling renewed investor confidence in this hospital sector stock.

Asarfi Hospital Limited, a micro-cap healthcare provider with a market capitalisation of ₹374.00 crores, delivered an exceptional performance in Q3 FY26, reporting consolidated net profit of ₹5.42 crores—a remarkable 102.24% surge year-on-year and 29.05% sequential growth. The Jharkhand-based hospital chain demonstrated robust operational momentum, with revenue reaching ₹46.10 crores, marking a 40.16% year-on-year expansion and 2.70% quarter-on-quarter growth.